CDKN2A and idiopathic pulmonary fibrosis: Collectively, these results provide mechanistic evidence linking CDKN2A-driven senescence pathways to the pathogenesis of IPF, and support the potential of CDKN2A as both a diagnostic biomarker and a therapeutic target.